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Summary. The difference between patients with CFS 
patient and healthy ones could, in principle, be detected 
by examining a variety of data. We systematically used 
the CAMDA 2006 available data sets in order to assess 
the patients’ discrimination using supervised and 
unsupervised techniques. Our results suggest that data 
sets that are predictive are the clinical as well as the 
microarray data sets. On the other hand, our analysis of 
the proteomics data suggests that subjects with diseases 
different from CFS could be among the healthy ones. 
Finally, we indicate a set of genes extracted from the 
microarray data and validate then with an automatic 
comparison with Gene Ontology information. A set of 
these genes with high GO proximity may contribute to 
CFS. 
 
Introduction. Chronic Fatigue Syndrome (CFS) is 
clinically defined through symptoms and disabilities 
that proved to be elusive when it was attempted to 
characterize them in terms of analysis-based diagnosis 
and etiology. The data sets provided for the CAMDA 
2006 contest contained clinical data, SNPs, blood data, 
proteomics and microarray genetic expression data. 
The integration between different sources has been 
explored in [Whistler et al, 2003], however not to the 
extension required by the CAMDA contest, in the 
sense that the authors addressed the problem of 
characterization of subgroups of CFS. [Vernon et al, 
2002] reported the identification of a set of genes that 
could play the role of biomarkers. However, as the 
authors stated, limitation in the number of samples and 
no independent validation influenced the validity of the 
results. Therefore, the problem of isolating biomarkers 
for the syndrome remains open. 
 
In this paper, we present our attempt to use the data 
available for the CAMDA contest in order to validate 
the diagnosis related to healthy patients and patients 
suffering from CFS. Our working hypothesis is, that  
given the elusiveness of the syndrome, the CFS 
labeling of patient records can possibly be wrong. 
Hence, in order to increase the probability of detecting 
relevant biomarkers, we would like to assess the 
inherent ability of each data set to produce a consistent 
classification. Depending on the data, we expect a 
difference in the way individuals are classified. In 
particular, we expect an optimal classification when 
using clinical data since CFS is defined in terms of 
symptoms.  From the literature, it seems that we cannot 
expect blood data to be very useful in order to predict 
the class. Moreover, we do not have any indication of 
the properties of the SNPs and proteomics data. After 
analyzing the aforementioned data sets, we validate our 
results using information derived from the Gene 
Ontology, which provides an automatic way of 
assessing the biological consistency of the discovered 
genes. 
 
The activities whose results are reported here were 
partially carried out as assignments during the course 
of Data Mining for Computer Science students of the 
University of Trento. In the following sections, we 
report our analysis and results for each one of the data 
sets. We also provide an interpretation of our results. 
  
Clinical Data. Using this data set we tried to analyze 
the real meaning of the column headers. Then, based 
on these results, we classified the data set using a 
Support Vector Machine (SVM) classifier. In our first 
attempt to classify the data, we used a multi-class SVM 
classifier (M-SVM) and all the features. The accuracy 
of the result was very low and, thus, we decided to 
remove some redundant features (e.g. columns “Intake 
classific”, “DOB”, “Exclusion”) and some instances 
(rows regarding patients excluded for medical or 
psychiatric reasons, and those having null-values in 
key-columns).  However, the accuracy obtained using 
the M-SVM on this new data set was still low (25% 
marked as “Incorrectly classified”).  
A possible explanation for this low accuracy is that the 
data were classified using 15 different class labels. In 
order to reduce the number of classes, we discarded all 
the instances not labeled as CFS or NF, reducing the 
data set to 58 instances (15 of which are CFS).  
Classification using binary-SVM produced a 
significantly higher accuracy (1.72% “Incorrectly 
classified”, see Table 1). 
Then we applied two filtering algorithms (see 
[Malossini, 2006]) in order to detect and remove 
possible incorrectly labeled instances. The two filtering 
algorithms we used (CL-stability and LOOE-
sensitivity) identified only one such suspect instance. 
This sample was removed from the data (for 
convenience, we name this last data set with 
57instancesCFS-NFonly). 
A B Classified as 
15 0 A - CFS 
1 42 B - NF 
Table 1 Confusion Matrix on cleaned clinical data 
 
Classification of the 57instancesCFS-NFonly data set  
using binary-SVM resulted in complete accuracy (no 
instances were marked as “Incorrectly classified”). 
 
SNPs Data. Our objective in the experiment was to 
find a reasonably correct relationship between the 
presence of particular SNPs and the state of health of a 
patient. From the given data sets named CAMDA_SNP 
description and CAMDA-SNP-Genotype data 4-14-05, 
we extracted a subset of data, ignoring patients labeled 
as ISF. Moreover excluded any patients without a 
corresponding record in the clinical data. The resulting 
patients were 111 females and 22 males. 
After the preprocessing of the data set we imposed 
several thresholds of correctness in order to distingush 
between good and bad results:  
>90%: we find a reasonable possible cause of CFS; 
75-90%: a good result but not so good to derive 
conclusions; 
40-75%: Not so bad, but not sufficient to derive 
conclusions; 
<40%: very bad. 
 
We used the functions of the Weka Data Mining tool 
[Weka] for attribute selection in order to assess if one 
or more attributes could predict the status of the 
patient. In particular we consider the individual 
predictive ability (cfssubset eval), the computation of 
Chi-squared statistics (chisquaredsubseteval), and a 
classifier based procedure (ClassifierSubseteval). The 
Chi-squared test showed that none of the single 
attributes was sufficient to predict the disease of a 
patient. The methods CFS Subset and Classifier Subset 
gave us a reasonably correct result, as a subset of the 
features seemed to be predictive. Those features were:  
POMC_3227244, TH_243542, MAOA_878819, 
MAOB_15959461, TPH2_8376042, COMT_2539273, 
COMT_3274705, NR3C1_11837659, NR3C1_11159943, 
NR3C1_1046361, NR3C1_1046360, 5HTT_7911132, 
5HTT_7911143, CRHR1_7450777, CRHR2_15872871, 
CRHR2_15960586, HTR2A_8695278; 
Trying to cluster or classify the data set with this 
features, however, led to reduced correctness. 
In our experiments, we used several clustering 
techniques: K-means, Expectation-Maximization (EM) 
and Cobweb. The results obtained after clustering 
were: K-means grouped 50.38% of the patients 
correctly, Cobweb provideed the worst results with 3% 
of them grouped correctly and, finally, EM gave us a 
correctness of 35.3%. Hence, the results obtained 
through clustering methods were totally inconclusive. 
The methods used for classification are: SVM, NBTree 
and Nearest Neighbor. SVM with Leave-one out 
validation classified only 54.14% of the patients 
correctly, and NBTree only 49.62%. Nearest Neighbor, 
with 5 neighbors, gave us a better correctness of 
62.41%. 
With our work on SNPs we did not obtain any results 
that could increase our knowledge on CFS nor give 
evidence that SNPs  information could discriminate the 
classes. 
 
Blood Data. The study of CAMDA’s supplied data 
about blood analysis was carried out in a number of 
steps. First of all, the data of each of the 34 “classical” 
blood exams was graphically visualized, dividing the 
subjects according to their gender and different state of 
their health, obtained by the two columns named 
“Intake Classific” and “Empiric” of the clinical data 
set. The progress of each graph was essentially the 
same for all exams: there were values out of the normal 
ranges with similar proportion in each group; so it was 
not possible to point out a trend that could help to 
assign a patient to a particular category. 
The second part of the study, focused on the 
classification and clustering of the blood analysis data.  
First of all, we decided to exclude from the next 
analysis all patients whose “Empiric” label contained 
the string “Med” because, as explained in the CAMDA 
document [Camda, 2006 prot], those patients had some 
other medical reasons that could suggest a wrong 
diagnosis. 
Therefore, the final group of analyzed patients 
contained 191 people and, because of the various 
values that the “Empiric” column could assume, we 
decided to classify the patients according to the 
following  criteria: 
1. healthy/ill: the patients with label “NF” were 
classified as healthy, and the other as ill; 
2. NF/ISF/CFS: the patients were classified as 
healthy if the value of the column “Empiric” 
contains the substring “NF”. The same 
approach was used for ISF and CFS; 
3. 9 distinct classes: the patients were classified 
according to the exact value of the associated 
column “Empiric” in the original clinical table 
Using Weka [WEKA] for the analysis, we chose  2 
classification methods: the Nearest-Neighbour and the 
Support Vector Machine (SVM), both using 10-fold 
crossing validation and leave-one-out. Besides, we 
tried to use different kernels for SVM (polynomial with 
exponents 2 and 3, and RBF with different parameters) 
but we always obtained bad classification results: in 
general the percentage of correctly classified ill 
patients was around 70%, while the percentage of 
correctly classified healthy patients was always below 
20%. 
Then, we tried to cluster the data using k-means, 
specifying 2, 3 and 9 clusters, according to the 
categories identified before. However the percentage of 
wrongly clustered instances ranged from 50 to 77% in 
this case as well. Hence, our task was to support an 
argument about the uselessness of blood data in CFS 
diagnosis, using numerical results. Such an argument 
may also be found in [Reeves, 2003], [Fukuda, 1994]. 
 
 
Figure 1. Accuracies for ill and healthy patients from 
the permuted datasets 
 
In order to support it, we did some random 
permutations of the patients’ “healthy/ill” label and we 
executed the classification described above once again. 
Figure 1 depicts the results obtained by SVM 
classification (the results of other classification 
methods are similar). 
As we can see, the percentages of the original CAMDA 
labels were very similar to the ones obtained with 
random labels: so we can conclude that all “classical” 
blood analysis data are not able to distinguish healthy 
people from the patients that actually have CFS. 
 
Proteomics Data. Proteomics research seeks to gain a 
better understanding of the role of proteins and gene 
function in the biology of a certain disease. The aim of 
our analysis was to identify serum biomarkers in CFS 
using Surface-Enhanced Laser Desorption/Ionization 
Time of Flight Mass Spectrometry (SELDI-TOF). To 
understand the molecular basis of CFS, we applied the 
hypothesis that different molecular patterns could be  
identified in samples from subjects with CFS compared 
to Quality Control subjects (QC).  
The proteomics data sets given by CAMDA were very 
spread. Fractionated serum of 63 samples ran in 
duplicate was spotted into ProteinChips, profiled under 
several analytical conditions (IMAC, H50, CM10LS, 
CM10HS) and then read with both high and low 
energy laser. 
According to the proteomic hypothesis we looked for 
the best fraction/ProteinChip combination that allowed 
us to discover biomarkers, i.e. peaks of protein 
intensities in CFS spectra that were not present in 
control serum. Given the spectra of samples coming 
from the same CAMDA classification group, we 
obtained an average spectrum for every condition, 
fraction and laser intensity of each group. One of the 
most relevant biomarkers discovered, comparing CFS 
pattern with QC pattern, was found with the 
combination fraction6/H50, and is shown in Figure 2A. 
In that figure, we can also notice that those patterns,  
supposed to be different, are on the contrary very close 
to each other, as if CFS couldn’t be well diagnosed 
using mass spectrometry. 
 
To validate this result, we provided a comparative 
analysis of the 7000 spectra given, based on the 
distance of spectra of 63 samples from QC. The 
method yielded, for every patient, the value of her  
 
Frequency
In
te
n
s
it
y
CFS
QC
 
Frequency
In
te
n
s
it
y
D
QC
 
Figure 2: Spectra from the 6
th
 fraction serum read with 
high laser and condition H50. Single biomarkers were 
found at frequency 12kHz (spectra plotted from 
frequency 8kHz to 13kHz). Top: Two patterns 
identified in samples from subjects with CFS and in 
QC subjects, according to CAMDA classification. 
Bottom: QC pattern and the average spectrum of 
diseased subjects (D) according to proteomic 
clustering. 
 
distance to the quality control. Given all the distances, 
we produced an ordered list of all patients from the 
closest to the furthest from  the QC. The ordering  
corresponded to a classification from the healthiest 
patient to the most diseased one. Euclidean distance 
and Pearson correlation were calculated between every 
sample spectrum and the relative QC spectrum for each 
condition and laser energy. The normalization of those 
distances, between 0 and 1, showed an obvious 
opposite correlation between the values of the 
Euclidean distance and  the values of the Pearson 
correlation (and thus similarity) measure. For that 
reason we merged the two ordered lists, obtaining for 
each set of spectra, the average distance of Euclidean's 
and inverted Pearson values. We obtained average 
distances for different energy lasers and conditions, 
and since values were very similar, it seemed natural to 
cluster all patients according to those average 
distances. Using k-means with k=3 we obtained three 
clusters: the cluster  H contains patients more similar to 
the QC (supposed to be healthy), the cluster D with 
distances close to 1 contains patients considered as 
correctly ill classified (with 
respect to all sick patients)  
 
correctly healthy classified 
(with respect to all healthy 
patients) 
 
percentages obtained with the 
original labels. 
diseased since they were very far from QC, and an 
intermediate cluster M, which contains all the other  
 
H M D  
8 21 2 NF 
5 4 2 ISF 
13 6 2 CFS 
Table 2: Confusion matrix of assignment to clusters. 
 
patients. Using three clusters, the predictive power of 
this analysis was very low: as shown in the confusion 
matrix of Table 2, proteomics predicted only 22% of 
the assignments to each classification group given by 
the CAMDA clinic data. 
Given the previous clustering we build, as explained 
before, D patterns as the average spectra of our 
diseased patients. Comparing QC patterns with the D 
patterns we discovered a lots of biomarkers, as well as 
biomarkers reported comparing it with CFS pattern. In 
particular, for the same fraction/ProteinChip 
combination used before, we can see (Figure 2B) that 
D and QC patterns are very different and the 
previously reported biomarker is even more evident 
(the intensity is triplicate). 
In other words using mass spectrometry we can 
identify few biomarkers that characterize clusters given 
by CAMDA. Moreover, through our distance based 
method we provided another classification whose 
results reported the same peaks and identified new 
ones. Those other peaks could not necessary identify 
biomarkers of CFS or CFS-like patient populations, as 
there are many biological factors that influence the role 
of proteins. Anyhow, as a consequence of our findings 
we can say that molecular patterns can be identified in 
samples from subjects with CFS compared to control 
subjects, but they are less significant than other 
patterns that could be identified from other groupings 
of same subjects. 
 
Microarray Data. Analyzing the gene expression data 
set we noticed that the values were very noisy; in fact, 
even in the same chip, the values of the same gene 
spotted in spatially different places were very unstable. 
In this scenario, the normalization process was very 
important; we started the normalization by aligning the 
medians of the sample values with the scaling 
operation. The scaling factor applied to all the values 
for a specific sample i was calculated in the following 
way:  
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In order to normalize the distribution of the samples, 
we applied the classical Quantile Normalization to the 
logarithms of the scaled values; we call the resulting 
data set Logarithmic Normalized Values (LNV) in 
order to distinguish it from another data set, called 
Cubic Root Normalized Values (RNV), resulting from 
the same process but with the cubic root operation 
instead of the logarithm. Since the clustering of the 
complete data set (as expected) did not give any 
interesting results, in this context the goal was to 
identify genes with statistically significant changes in 
expressions between the samples labeled as CFS 
(fatigued – 89 samples) and the samples labeled as NF 
(non fatigued - 41); in this phase we ignored the IFS 
samples in order to improve sensibility. We applied 
two statistical methods to the two data sets (NV and 
RNV): conventional t-tests and Significance Analysis 
of Microarrays (SAM) [Tusher, 2001]. We obtained 4 
analyses, but varying the parameters of the methods 
(alpha for t-test and delta for SAM) we obtained a set 
of possible results; from this set we selected the most 
precise results, obtaining 9 consistent sets of genes. A 
set of genes is considered precise enough if it respected 
the following two conditions: 
1. The analysis parameters must be restrictive 
enough (the alpha parameter for the t-test 
must be under a threshold Thalpha and the delta 
parameter for SAM must generate a FDR 
median value under another threshold Thdelta). 
2. The genes provide high unsupervised 
classification accuracy. The confusion matrix 
between the CFS and NF labeled samples and 
the two clusters of samples obtained applying 
the (2 class) k-means clustering on the set of 
genes, must respect the following constraint:  
precisionraterate ThNFCFS >  
where rateCFS  is the percentage of the right 
classified CFS samples and rateNF  is the 
percentage of the correctly classified NF 
samples. We were aware that there existed 
clustering algorithms more precise than k-
means, but the goal of this clustering was a 
relative comparison between the analyses, not 
an absolute measurement.  
The results of four analyses (one for each main group) 
are available on the web as additional material
1
. 
We chose to give each gene isolated by one of the nine 
best analyses, a value which represented the confidence 
level that we had on it. This value for a gene is simply 
calculated as the percentage of consistent analyses in 
which it appeared; the table of the best 30 genes is 
shown in Table 3. 
We also tried to apply the same method on the 
57instancesCFS-NFonly, finding worse values of 
accuracy on the confusion matrices obtained by the k-
means clustering on the resulting sets of genes; in 
particular, the best analysis on 57instancesCFS-NFonly 
produced an accuracy value of 71% against a mean 
accuracy on the original set of 77%. 
In conclusion, we can assume that the set of genes 
shown in Table 3 are the most likely to be in relation 
with CFS. 
Integration with GO information. In order to verify 
and test the biological plausibility of the genes that 
were isolated as differential expressed in the CFS  
                                                           
1
http://dit.unitn.it/~blanzier/TN2camda06add_data.htm 
GENES DETECTED IN: 
AK075162 XM_087606  8 analyses out of 9 
NM_014149 BC001439 
BC035807 AF172066 AF151022 
AF100928 
7 analyses out of 9 
AF449187 BC007072 AF492830 
NM_006189 BC004166 
BC002462 
6 analyses out of 9 
NM_006278 S76825 AK022571 
NM_002280 
5 analyses out of 9 
BC022270 AK024524 
AK095113 NM_004364 
AB002380 NM_005263 
AF113616 D37827 NM_000570 
AF142099 NM_015846 D14665 
AF075430 NM_003608 
NM_001256 AK000759 
BC025394 BC012070 AF035933 
AB083606 
4 analyses out of 9 
Table 3 Genes differentially expressed in microarray 
data 
 
patient and in the healthy ones we assessed their 
relation with GO structure. We took the list of genes 
with their amino-acid sequence and we executed the 
Blast of these sequences against Uniprot database 
(updated 9 december 2005). Considering only 
biological processes, for each alignment of a gene, we 
assigned its weight to all its pertinent GO nodes 
(udpdated 10 january 2006), "bringing up" the same 
weight to ancestors (a node has a weight corresponding 
to the sum of its own weight plus all the weights of its 
children). Then we computed the information content 
of each node dividing the number of its descendents by 
the total number of nodes in the graph and calculating 
the natural logarithm of the resulting value. For each 
gene, the output were the GO with the maximum value 
of information content multiplied for the weight. In this 
way we choose the nodes that better characterize the 
query sequence in term of scoring and information 
associated to the GO nodes. We applied this technique 
to the list of genes in Table 3 and we obtained 
subgroups of them with respect to GO graph: the 
relation between GO terms is evaluated with Lin’s 
formula [Lin 1998]. The subgroups are: 
1) AF151022 AF492830 AK000759 AK075162 
BC002462 BC004166 BC007072 BC022270 
BC035807 D37827 NM_004364 NM_006278 
NM_014149 GO:0008152 2) AF040958 GO:0005975 
3) AF356527 GO:0050789 4) AF374726 GO:0007165 
5) AK093494 GO:0008152 6) BC015761 GO:0050896 
7) XM_087062 GO:0008152. 
These 13 sequences of the first subgroup are annotated 
with the general GO term metabolism 0008152 and so 
it is difficult inferring  in which type of metabolic 
pathway they are involved. Probably this information, 
coupled with microarray expression data, is 
informative about some transcription regulation  
pathway in which these genes are involved as emerged 
by a more accurate analysis of blast results. 
 
Conclusions. The clinical data after cleaning and data 
selection were able to correctly classify the distinction 
between CFS and NF. This is not surprising given that 
the diagnosis is based on clinical information. We 
cleaned the data in a way that left us with a completely 
consistent and classifiable data set. SNPs and Blood 
data sets were not effective in classification. 
Proteomics data analysis detects patterns less evident 
in CFS patients of the one  detected in other groups. 
Analysis of gene differentially expressed in microarray 
data identify a set of genes. There  is a consistency 
between this genes in terms of proximity in Gene 
Ontology under the general term metabolism. The 
indication that some metabolic pathway could be 
involved in CFS is consistent with the literature. 
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